SecBot SecBot
EFFECT ·Filed May 14, 2026

LABT

Lakewood-Amedex Biotherapeutics Inc.
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC9999999995-26-001622
IPO/offering going effective
Actionable Insight ▼ Bearish

Monitor for any selling stockholder Form 144 filings or volume spikes. The overhang may pressure the stock near-term, especially given the company's pre-revenue status and lack of new capital.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
LABT ▼ -88.01% at T+60d
SHORT call ✓ call won +88.01% · α vs SPY +91.60% · entry $19.60 → $2.35
Entry = T+0 close
May 14, 2026
via day close
T+1d
-23.47%
call +23.47% · α +22.27%
$15.00
settled 5mo ago
T+5d
-60.71%
call +60.71% · α +59.99%
$7.70
settled 5mo ago
T+20d
-60.71%
call +60.71% · α +59.86%
$7.70
settled 5mo ago
T+60d
-88.01%
call +88.01% · α +91.60%
$2.35
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

The SEC declared effective the S-1 registration statement for Lakewood-Amedex (LABT), allowing selling stockholders to resell up to 9,647,726 shares of common stock. The company will not receive any proceeds from these sales, creating potential dilution overhang for existing shareholders with no capital infusion.

Key Facts

  • Effectiveness date: May 13, 2026 (filed May 14, 2026).
  • Registration covers 9,647,726 shares held by selling stockholders (including conversion of Series C Preferred and advisory shares).
  • Company receives no proceeds from the resale.

Financial Impact

Registered shares represent ~23% of current market cap ($42M) at ~$4.35/share, creating significant overhang.

dilutionstock price

Risk Factors

  • Selling stockholders may begin immediate sales, pressuring share price.
  • No new capital raised despite dilution risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001622
Document: 9999999995-26-001622-index.html9999999995-26-001622
Document: 9999999995-26-001622.txt9999999995-26-001622
8 reports for LABT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for LABT — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
EFFECT
BULLISH ★ 6/10
$1.67 $0.3100▼ −81.44%▼ −79.96%$0.2644 (−84.17%)
Sep 18, 2026
5w ago
S-1
BEARISH ★ 5/10
$2.05 $0.5834▲ +71.54%▲ +70.63%$0.2644 (+87.10%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$0.6022 $0.1890▼ −68.62%▼ −68.93%$0.2644 (−56.09%)
May 14, 2026
23w ago
EFFECT
BEARISH ★ 5/10
$19.60 $7.70▲ +60.71%▲ +59.86%$0.2644 (+98.65%)
May 6, 2026
24w ago
3
NEUTRAL ★ 2/10
$33.00 $6.70▼ −79.70%▼ −80.51%$0.2644 (−99.20%)
Apr 20, 2026
27w ago
EFFECT
NEUTRAL ★ 6/10
—awaiting T+20——
Apr 1, 2026
29w ago
S-1/A
BEARISH ★ 5/10
—awaiting T+20——
Mar 11, 2026
32w ago
S-1/A
NEUTRAL ★ 4/10
—awaiting T+20——
Showing 8 of 8

US Market Status

Market Open — Closes in 3h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026